手术切除联合射频消融治疗结肠癌肝转移疗效分析
2016-09-07安永德郭亚民范龙鑫
安永德,郭亚民,范龙鑫
手术切除联合射频消融治疗结肠癌肝转移疗效分析
安永德,郭亚民,范龙鑫
目的探讨手术联合射频消融治疗结肠癌肝转移患者的治疗效果。方法对2008年1月至2014年3月我科诊治的结肠癌肝转移接受结肠癌根治术和肝内肿瘤灶切除治疗的17例和结肠癌根治术后对肝内肿瘤行射频消融(RFA)治疗的12例患者的临床资料进行回顾性分析。绘制Kaplan-Meier生存曲线,进行生存分析。结果单纯手术治疗的17例患者均于术后20个月内死亡,平均生存时间为(13.412±0.912)月,而手术联合射频消融治疗的12例患者随访6~28个月,平均生存时间为(18.496±2.139)月(P<0.05);RFA治疗后患者均出现不同程度的恶心、呕吐、胸闷、右上腹痛、发热,血清ALT和AST轻度升高。结论手术联合射频消融治疗结肠癌肝转移是一种可行的、安全的、有效的方法,可以明显延长患者的生存期。
结肠癌;肝转移癌;手术切除;射频消融
【Abstract】Objective To investigate the efficacy of radiofrequency ablation after resection of colorectal caicinomain patients with liver metastases.Methods 17 patients with colorectal liver metastases had radical operation and hepatolobectomy and 12 had radical operation and radiofrequency ablation(RFA)from January 2008 to March2014 in our series.Their clinical materials was retrospectively analyzed,and the survival curve was drawn by the Kaplan Meier.Results All the patients in radical operation and hepatolobectomy died within 20 months after surgery,and the average survival time was(13.412±0.912)months.The patients receiving RFA was followed-up for 6 to 28 months,and the average expected survival time was(18.496±2.139)months,which was significantly longer than in hepatolobectomy group(P<0.05).Conclusion The radical operation and radiofrequency ablation for treating colorectal liver metastases was feasible,safe and effective,and it can obviously prolong the patient’s survivals.
【Key words】Liver metastases;Colorectal cancer;Radical operation;Radiofrequency ablation
结肠癌是我国消化道常见恶性肿瘤之一。随着经济的发展,人们的精神、心理、生活压力以及膳食结构多样化等因素的改变,该病的发病率呈逐年上升趋势。肝脏作为结肠癌血行转移最主要的靶器官,所以结肠癌肝转移十分常见。由于仅有10% ~20%肝转移瘤在发现时能够被手术切除,因此绝大多数患者失去了手术机会。目前,结肠癌肝转移的治疗仍是结肠癌治疗工作中的重点和难点,尤其是对肝脏多发或无法切除的转移瘤的治疗。因此,多种方法联合治疗已成为治疗结肠癌肝转移的趋势。本文总结分析了我科收治的29例结肠癌肝转移患者,其中12例接受手术联合射频消融(Radiofrequency ablation,RFA)治疗的患者预后较单纯手术组明显优越,现将结果报道如下:
1 资料与方法
1.1临床资料2012年1月至2014年3月我科收治的结肠癌并发肝转移患者29例,男性12例,女性17例;……
